We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV

By LabMedica International staff writers
Posted on 08 May 2025

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1. More...

25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for TB relies on sputum samples, which are collected by deep coughing and expectoration of lung secretions. The World Health Organization (WHO) recommends molecular sputum tests for individuals living with HIV, in addition to urine antigen detection (TB-LAM). However, access to these tests remains limited in many regions, and they are not suitable for all individuals with HIV. Specifically, people with HIV often have difficulty producing sputum; more than half of those in advanced stages of the disease are unable to do so. Moreover, the bacteria concentration in the sputum is frequently too low to detect. To overcome this challenge, researchers have proposed using a molecular test, which is currently employed on respiratory samples, for stool samples instead to test for TB.

Cepheid’s (Sunnyvale, CA, USA) Xpert MTB/Ultra molecular diagnostic test, which has thus far only been recommended for children, could also be used to diagnose tuberculosis in HIV-positive adults. This was the central conclusion of the Stool4TB Alliance study, led by the Barcelona Institute for Global Health (ISGlobal, Barcelona, Spain). Published in The Lancet Microbe, the results could potentially lead to a paradigm shift in diagnosing TB among this population. The test is currently recommended for children who have difficulty producing sputum. The study, conducted between December 2021 and August 2024 in medical centers across three African countries, included 677 HIV-positive patients aged 15 and older with suspected TB.

Participants provided sputum, urine, stool, and blood samples. The results revealed that the stool test had a sensitivity of 23.7% and a specificity of 94.0% when compared to the reference standard. For patients with CD4 counts below 200 cells/μl, sensitivity increased to 45.5%. CD4 lymphocytes are immune cells that are damaged by HIV infection, making individuals with CD4 counts below 200 more susceptible to serious opportunistic infections, including tuberculosis. Additionally, the Stool Ultra test identified cases of TB that were missed by other methods, such as TB-LAM, Ultra sputum tests, or bacterial cultures.

“People living with HIV are at higher risk of developing pulmonary tuberculosis, but diagnosis in these cases is particularly challenging due to the low sensitivity of conventional tests,” explains George William Kasule, a PhD student at ISGlobal and the University of Barcelona, and the first author of the study. “The variety of samples obtained in this study allowed us to compare the sensitivity and specificity of the Stool Ultra test with a microbiological reference standard consisting of three WHO-recommended tests: TB-LAM in urine, liquid culture, and Xpert Ultra from sputum.”

Related Links:
ISGlobal


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: Schematic diagram of multimodal single-cell MSI using tapping-mode scanning probe electrospray ionization (Photo courtesy of Yoichi Otsuka)

New Technology Improves Understanding of Complex Biological Samples

Tissues are composed of a complex mixture of various cell types, which complicates our understanding of their biological roles and the study of diseases. Now, a multi-institutional team of researchers... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.